Brief Psychotic Disorder: Clinical Trials

11 trials for Brief Psychotic Disorder, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 1 enrolling by invitation, 1 recruiting, 1 terminated. 10 Not applicable, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable10Completed 7, Recruiting 1, Terminated 1, Unknown 1
Phase 21Enrolling by invitation 1

Follow Brief Psychotic Disorder: new trials by email Literature Review of Brief Psychotic Disorder trials Research Report on Brief Psychotic Disorder

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
FEEL-GOOD: A Multicenter Trial of a Mindfulness-Based Group Therapy in Young Adults With Early Psychosis
FEEL GOOD, Treatment as Usual (TAU) - Delusional Disorder, Brief Psychotic Disorder
Not applicableRecruitingStephanie Mehl2522026-05-272026-09-22
Accelerated rTMS for Psychomotor Slowing
cTBS (continuous Theta Burst Stimulation) - Schizophrenia; Psychosis, Schizophrenia and Related Disorders
Not applicableTerminatedUniversity of Bern252023-09-222024-09-25
Benefits of Combining MCT With CR in the Recovery of Patients With Psychotic Spectrum Disorders
Cognitive Remediation (REHACOP), Metacognitive Training (MCT) - Schizophrenia, Schizophreniform Disorders
Not applicableUnknownUniversitat Autonoma de Barcelona1602022-09-012024-05-23
Rituximab Treatment for Psychosis And/or Obsessive Compulsive Disorder with Probable Immune System Involvement
Rituximab - Obsessive-Compulsive Disorder, Obsessive-Compulsive Behavior
Phase 2Enrolling by invitationUppsala University Hospital402022-05-012024-11-19
Feasibility of a Novel Process-based Treatment for Patients With Psychosis
Metacognitive and Defusion Training - Schizophrenia, Schizotypal Disorder
Not applicableCompletedMax-Planck-Institute of Psychiatry372021-05-102023-10-23
Targeting Physical Health in Schizophrenia: Physical Activity Can Enhance Life Randomized Control Trial
PACE-Life, Exercise Intervention - Schizophrenia, Schizoaffective Disorder
Not applicableCompletedUniversity of North Carolina, Chapel Hill502019-12-202022-09-22
Overcoming Psychomotor Slowing in Psychosis (OCoPS-P)
1 Hz rTMS, iTBS, Placebo - Schizophrenia and Related Disorders, Schizophrenia
Not applicableCompletedUniversity of Bern1032019-03-252023-02-14
Targeting Physical Health in Schizophrenia: Physical Activity Can Enhance Life
Exercise Intervention- PACE-Life - Schizophrenia, Schizoaffective Disorder
Not applicableCompletedUniversity of North Carolina, Chapel Hill172018-12-062020-09-21
Effectiveness of the Individualized Metacognitive Training (EMC+) in People With Psychosis of Brief Evolution
MCT+ - Brief Psychotic Disorder, Psychosis; Episode
Not applicableCompletedFundació Sant Joan de Déu702015-01-012020-06-12
Pilot-trial of Emotion-focused Cognitive Behavior Therapy for Patients With Schizophrenia
CBT-E, Treatment as Usual - Schizophrenia, Delusional Disorder
Not applicableCompletedPhilipps University Marburg642014-01-012020-03-04
An Integrated Program for the Treatment of First Episode of Psychosis
Integrated Treatment, Community Care - Schizophrenia, Schizoaffective Disorder
Not applicableCompletedNorthwell Health4042010-07-012021-10-26

Narrower conditions

Psychotic Disorders (11)  ·  Schizophrenia (10)  ·  Schizophrenia, Paranoid (5)  ·  Motor Activity (3)  ·  Emotional Regulation (2)  ·  Mental Disorders (2)  ·  Psychomotor Disorders (2)  ·  Bipolar Disorder (1)  ·  Compulsive Behavior (1)  ·  Depressive Disorder, Major (1)  ·  Mania (1)  ·  Obsessive-Compulsive Disorder (1)  ·  Recurrence (1)  ·  Schizophrenia Spectrum and Other Psychotic Disorders (1)  ·  Schizotypal Personality Disorder (1)

Broader conditions

Schizophrenia Spectrum and Other Psychotic Disorders (10)  ·  Mental Disorders (9)  ·  Behavior (6)  ·  Nervous System Diseases (3)  ·  Neurobehavioral Manifestations (3)  ·  Neurologic Manifestations (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Signs and Symptoms (3)  ·  Self-Control (2)  ·  Social Behavior (2)  ·  Anxiety Disorders (1)  ·  Bipolar and Related Disorders (1)  ·  Depressive Disorder (1)  ·  Disease Attributes (1)  ·  Impulsive Behavior (1)

Interventions

Therapeutics (2)  ·  Cognitive Remediation (1)  ·  Rituximab (1)  ·  Transcranial Magnetic Stimulation (1)

Sponsors

University of Bern (2)  ·  University of North Carolina, Chapel Hill (2)  ·  Fundació Sant Joan de Déu (1)  ·  Max-Planck-Institute of Psychiatry (1)  ·  Northwell Health (1)  ·  Philipps University Marburg (1)  ·  Stephanie Mehl (1)  ·  Universitat Autonoma de Barcelona (1)  ·  Uppsala University Hospital (1)

Countries

Germany (3)  ·  United States (3)  ·  Switzerland (2)  ·  Spain (1)  ·  Sweden (1)

Top investigators

Ana Barajas Velez (1)  ·  Andreas Bechdolf, Prof. Dr. (1)  ·  David L Penn, PhD (1)  ·  David Penn, PhD (1)  ·  Janet L Cunningham, MD PhD (1)  ·  Johannes M Kopf-Beck, PhD (1)  ·  John Kane, MD (1)  ·  Sebastian Walther, MD (1)  ·  Sebastian Walther, Prof. Dr. med (1)  ·  Stephanie Mehl, Ph. D. (1)  ·  Stephanie Mehl, Prof. Dr. (1)  ·  Susanne Lucae, MD, Prof. (1)  ·  Tania M. Lincoln (1)  ·  Tilo Kircher (1)  ·  Winfried Rief (1)

Results publications

PMID 25727536, PMID 25830446, PMID 26481174, PMID 28427286, PMID 28945118, PMID 29444349, PMID 30139553, PMID 31026764, PMID 31084291, PMID 32052566, PMID 33493778, PMID 35026597, PMID 36623822, PMID 37657279, PMID 38416468, PMID 40643782, PMID 41920015, PMID 42531158, PMID 42768802

NIH funding

R34MH111852 (2), 2018 (1), 2019 (1)